Repligen Corp (NASDAQ:RGEN) shares, rose in value on Wednesday, May 07, with the stock price down by -2.70% to the previous day’s close as strong demand from buyers drove the stock to $126.88.
Actively observing the price movement in the last trading, the stock closed the session at $130.40. Referring to stock’s 52-week performance, its high was $182.52, and the low was $102.96. On the whole, RGEN has fluctuated by 9.28% over the past month.
With the market capitalization of Repligen Corp currently standing at about $7.13 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 708.66M, with a low estimate of 168.8M and a high estimate of 179.1M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 174.62M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RGEN’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of RGEN currently trading nearly -5.24% and -8.41% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.88, while the 7-day volatility ratio is showing 5.03% which for the 30-day chart, stands at 6.82%. Furthermore, Repligen Corp (RGEN)’s beta value is 1.19, and its average true range (ATR) is 8.34.
A comparison of Repligen Corp (RGEN) with its peers suggests the former has fared considerably weaker in the market. RGEN showed an intraday change of -2.70% in last session, and over the past year, it shrunk by -24.05%%.
Data on historical trading for Repligen Corp (NASDAQ:RGEN) indicates that the trading volumes over the past 3 months, they’ve averaged 819.50K. According to company’s latest data on outstanding shares, there are 56.18 million shares outstanding.
Nearly 5.47% of Repligen Corp’s shares belong to company insiders and institutional investors own 100.80% of the company’s shares. The stock has fallen by -11.85% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RGEN stock heading into the next quarter.
